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Abstract
In the USA, mortality among patients with chronic kidney disease (CKD) and end-stage renal 
disease has declined over the past two decades. By contrast, new data indicate that the rate of 
CKD-associated deaths is increasing worldwide. This important finding highlights CKD as a 
major contributor to global morbidity and mortality.
Despite increasing recognition of the high prevalence and associated mortality of pre-
dialysis and dialysis-dependent chronic kidney disease (CKD) in industrialized nations such 
as the USA1,2 and the UK,3 a large knowledge gap remains with regards to the 
epidemiology of CKD in less-developed countries. A new report from the Global Burden of 
Disease (GBD) Study has reduced this gap and identified CKD as an increasing cause of 
mortality worldwide.4
In their recent study, the GBD 2013 Mortality and Causes of Death Collaborators 
systematically quantified and compared the magnitude of all-cause and cause-specific 
mortality (306 causes of death and disability) in 188 countries between 1990 and 2013.4 
Building on prior reports from 1990 and 2010,5,6 these latest data highlight global 
epidemiologic achievements made between 1990 and 2013, including an increase in life 
expectancy from 65.3 years to 71.5 years, a rise in the mean age of death from 46.7 years to 
59.3 years, and a substantial decline in child mortality, largely as a result of a reduction in 
deaths from infectious causes.4 Importantly, the decrease in premature mortality has led to a 
shift towards a larger proportion of deaths occurring in people aged >80 years, and increased 
longevity has led to a larger burden of non-communicable chronic illnesses in this older 
population. These findings should be used to frame and prioritize national, regional and 
global health policies.
Although the GBD 2013 report shows that age-standardized mortality has improved for 
most communicable and non-communicable conditions, CKD is among a small number of 
diseases each accounting for >100,000 deaths in 2013 for which death rates have 
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substantially risen since 1990 (Figure 1). Age-standardized mortality due to CKD increased 
by 36.9% from 11.6 deaths per 100,000 population in 1990 to 15.8 deaths per 100,000 
population in 2013, making this disease the 19th leading global cause of years of life lost in 
2013 compared with the 36th leading cause in 1990. The report also reveals the 
disproportionate burden of CKD-associated deaths across various geographic regions. CKD 
was among the top ten causes of years of life lost in Latin America and the Caribbean, 
Southeast and East Asia and Oceania, North Africa and the Middle East, as well as in the 
high-income nations Singapore, Greece and Israel.
The new data advance our knowledge of the global epidemiology of CKD in several key 
ways. By synthesizing vital registration data, sibling history survey data, sample registration 
data and household recall of deaths from 21 regions and 7 supra-regions, this ‘big-data’ 
report provides new information on the mortality burden of CKD in parts of the world that 
were not previously included in major collaborative studies from groups such as the CKD 
Prognosis Consortium7 and the United States Renal Data System (USRDS).2 Although the 
high prevalence of CKD in developing nations such as China is increasingly recognized 
owing to reliable national survey data,8,9 the GBD Study 2013 highlights other regions in 
need of greater study, such as Latin America and the Caribbean; CKD is among the top five 
causes of years of life lost in Mexico, El Salvador, Nicaragua and Barbados. USRDS data 
show that the unadjusted and adjusted mortality rates for subpopulations of patients with 
CKD in the USA (for example, Medicare beneficiaries aged ≥66 years) and for patients with 
ESRD have decreased in the past two decades,2 whereas the GBD Study 2013 highlights 
CKD as a neglected disease and a major global contributor to loss of health and life.4
Several limitations bear mention with regards to interpretation of the new findings. First, as 
cause of death was ascertained using ICD-9 and ICD-10 codes, the trends in CKD mortality 
over time might have been influenced by increasing recognition of the disease and, 
therefore, greater likelihood of CKD coding. Furthermore, the reliance on diagnostic code 
data alone to define CKD as a cause of death might have resulted in under-coding of people 
with early stages of CKD, leading to a larger proportion of reports of advanced CKD and 
subsequent CKD-associated deaths. Second, although mortality is well known to increase 
with severity of CKD, the report does not distinguish between pre-dialysis and dialysis-
dependent CKD as a cause of death. Third, given that cardiovascular deaths largely account 
for mortality among patients with CKD, the reliance on cause of death codes might have 
resulted in under estimation of the numbers of CKD-associated deaths; indeed, ischaemic 
heart disease was among the top three causes of death in 32 developed countries and in 
many less-developed countries. Fourth, acute kidney injury (AKI) was not included as a 
cause of death in the analysis. AKI is associated with increased mortality10 and given its 
bidirectional relationship with CKD (AKI is a major risk factor for CKD and vice versa), it 
may account for CKD-associated deaths not captured in the GBD 2013 report.4
In conclusion, the GBD Study 20134 conveys unprecedented information with regards to the 
global burden of CKD-associated mortality and its disproportionate burden across under-
recognized regions. An urgent need exists to obtain further data on the prevalence and 
severity of CKD in less-developed nations, as well as granular data on risk factors for CKD-
associated mortality that might be country-specific, such as limited CKD education and 
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awareness; reduced availability and access to health care resources; heterogeneous treatment 
and/or practice patterns (such as use of haemodialysis, peritoneal dialysis and kidney 
transplantation) and differential comorbidity burdens across populations.
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“... [CKD was] the 19th leading global cause of years of life lost in 2013...”
Rhee and Kovesdy Page 4
Nat Rev Nephrol. Author manuscript; available in PMC 2015 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. 
Leading causes of >100,000 deaths per year in 2013 for which age-standardized death rates 
have increased since 1990.4 Abbreviation: HCV, hepatitis C virus.
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